Avant Brands Inc
TSX:AVNT

Watchlist Manager
Avant Brands Inc Logo
Avant Brands Inc
TSX:AVNT
Watchlist
Price: 0.78 CAD 1.3% Market Closed
Market Cap: 8.4m CAD

Relative Value

The Relative Value of one AVNT stock under the Base Case scenario is 4.19 CAD. Compared to the current market price of 0.78 CAD, Avant Brands Inc is Undervalued by 81%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AVNT Relative Value
Base Case
4.19 CAD
Undervaluation 81%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
88
Median 3Y
1.4
Median 5Y
39.5
Industry
2.5
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-143.4
Industry
21.8
vs History
19
vs Industry
21
Median 3Y
4.3
Median 5Y
-249.7
Industry
16.6
vs History
vs Industry
9
Median 3Y
-17.2
Median 5Y
-189.5
Industry
24
vs History
92
vs Industry
78
Median 3Y
0.7
Median 5Y
19.9
Industry
2.1
vs History
80
vs Industry
83
Median 3Y
1.8
Median 5Y
39.8
Industry
2.7
vs History
79
vs Industry
80
Median 3Y
5.1
Median 5Y
110.2
Industry
5.3
vs History
36
vs Industry
51
Median 3Y
3.1
Median 5Y
-349.4
Industry
12.8
vs History
12
vs Industry
47
Median 3Y
-15
Median 5Y
-240.3
Industry
16.2
vs History
19
vs Industry
10
Median 3Y
6.6
Median 5Y
-248.1
Industry
15.1
vs History
12
vs Industry
10
Median 3Y
8.3
Median 5Y
-221.1
Industry
17.7
vs History
88
vs Industry
77
Median 3Y
0.7
Median 5Y
15.3
Industry
1.9

Multiples Across Competitors

AVNT Competitors Multiples
Avant Brands Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Avant Brands Inc
TSX:AVNT
8.4m CAD 0.2 -0.4 2.5 6.5
US
Eli Lilly and Co
NYSE:LLY
739.9B USD 15.1 66.6 35.8 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
375.3B USD 4.2 17.2 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.6 19.1 13.3 15.2
CH
Roche Holding AG
SIX:ROG
206.8B CHF 3.4 25 9.4 11
CH
Novartis AG
SIX:NOVN
192.2B CHF 4.5 18.8 11.1 14.8
UK
AstraZeneca PLC
LSE:AZN
160.3B GBP 4 28.2 130.7 197.2
US
Merck & Co Inc
NYSE:MRK
203.6B USD 3.2 11.7 8.7 10.5
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
144.3B USD 2.3 18.3 7.8 10.9
P/E Multiple
Earnings Growth PEG
CA
Avant Brands Inc
TSX:AVNT
Average P/E: 25.6
Negative Multiple: -0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.6
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.1
18%
1.1
CH
Roche Holding AG
SIX:ROG
25
32%
0.8
CH
Novartis AG
SIX:NOVN
18.8
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.2
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.7
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.3
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Avant Brands Inc
TSX:AVNT
Average EV/EBITDA: 394.5
2.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.8
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
11.1
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.7
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Avant Brands Inc
TSX:AVNT
Average EV/EBIT: 1 698.1
6.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15.2
14%
1.1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
14.8
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.2
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.5
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.9
10%
1.1